Once again, it is that time of the year when we begin our annual series highlighting some of the most promising startups from across Europe. Each edition takes a country-by-country look at the teams and technologies shaping the continent’s entrepreneurial landscape. For 2026, we are starting with Austria, opening the series with a closer look The post 10 Austrian startups to keep an eye on in 2026 and beyond appeared first on EU-Startups.

Paris-based Spore.Bio, a BioTech startup developing AI-based microbiology testing technology, today announced that it has secured multi-million-euro funding from the Google.Org Fund for AI in Science. Additionally, it has also launched Spore.Labs, an AI-native research division focused on tackling the critical challenges in public health.  The Google.org AI for Science Fund is a multi-million-dollar initiative The post French BioTech Spore.Bio secures multi-million-euro Google.org funding and launches AI-native research unit appeared first on EU-Startups.

Cologne-based United Manufacturing Hub (UMH), an open-source industrial data management platform for modern factories, today announced a €5 million funding round to accelerate its mission to build the foundational data layer for global manufacturing. The round was led by KOMPAS VC, with participation from seed + speed Ventures, Sustainable Future Ventures, and Archimedes New Ventures. The post Cologne’s United Manufacturing Hub raises €5 million to fix the data layer holding global manufacturing back appeared first on EU-Startups.

Barcelona-based pre-Seed manager 4Founders Capital today announced they will be taking a new step forward after surpassing €130 million in AUM with the launch of their first fund specialised in hotel real estate; 4Founders Capital Hospitality. The new vehicle will have an ​investment capacity of €60 million, a six-year duration, and has already received approval The post 4Founders Capital launches €60 million Hospitality fund against backdrop of strong hotel investment flows in Spain appeared first on EU-Startups.

Dark Blue Therapeutics, a British discovery and development BioTech company innovating the next generation of precision oncology medicines, has been acquired by US-based global BioTech company Amgen, in a transaction valued at up to €718 million ($840 million). Dark Blue’s lead candidate DBT 3757 is a first-in-class therapy in IND-enabling studies for leukemia, with the The post Amgen acquires Oxford-based Dark Blue in deal worth up to €718 million to advance leukemia programme appeared first on EU-Startups.

Biographica, a British AI startup innovating how the agricultural industry develops new crop varieties, today announced an €8 million (£7 million) funding round to accelerate the creation of climate-resilient, productive and nutritious crops – addressing global food security challenges driven by climate change, population growth, and limited natural resources. The round was led by Faber The post Global food security concerns drive €8 million raise for London’s AgTech startup Biographica appeared first on EU-Startups.